"Global Hepatocellular Carcinoma Drugs Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032
Executive Summary:
The global hepatocellular carcinoma drugs market was valued at USD 1.21 billion in 2024 and is expected to reach USD 2.27 billion by 2032